How might the entrance of new formulations of buprenorphine improve treatment in vulnerable populations?
Annie Kuster
The Public Record
Annie L. McLane Kuster is an American politician serving as the U.S. Representative for New Hampshire's 2nd congressional district since January 3, 2013. A member of the Democratic Party, Kuster has focused on issues such as healthcare, women's rights, and economic development throughout her tenure in Congress. She has been an advocate for expanding access to affordable healthcare and has worked on initiatives to support small businesses in her district.
In my view, passing H.R. 4712 is a common sense step that will be good for orphan drug policy, good for public health, and good for the millions of Americans with opioid use disorder.
Thank you. And how is the legislation before us today effective in closing the loophole that has prevented other companies from entering the market with new formulations?
So, you think overall that would be beneficial for Americans, including vulnerable populations and those that are receiving their medically-assisted treatment, that this will improve access----
I have introduced legislation that we call the Humane Correctional Health Care Act and what this would do is continue Medicaid coverage during incarceration.
New Hampshire has some very innovative models coming out of the opioid epidemic.
We have people incarcerated for drug-related crimes, getting no treatment for their mental health or substance use disorder.
In my seven years in Congress, this is one of the best, most productive hearings I have been at.
Today the House took sweeping bipartisan action to address PFAS contamination that has proliferated across communities in America. These forever chemicals have been linked to negative health effects, including cancer, impaired child…
I am here today on behalf of my great-niece, Leah, who passed from SIDS just over a year ago.
I find it extraordinary, when I went to do the research after losing Leah to understand the scope of this, it is quite an extraordinary public health success that we cut the number of unexpected infant deaths in half.
I want to support the additional research from the truly unexpected, unexplained deaths, but I also want to focus on this issue of education and training.
I include my statement in the Record regarding the 75th anniversary of the Battle of the Bulge in favor of the Articles of Impeachment. Madam Speaker, earlier this week, I returned from a bipartisan trip to Belgium to commemorate the 75th…
I have long called for Congress to take meaningful action to lower prescription drug costs by allowing the direct negotiation of prescription drug prices by Medicare. I am proud to cosponsor H.R. 3, the Lower Drug Costs Now Act, and I am…
If we're giving them permission to send this medication into our country for sale, somebody's making a profit.
Thank you, Chairwoman DeGette, for your continued leadership on ensuring the safety and inspection of our drug supply chain.
I hope you will work with our committee to tighten this up, because these loopholes sound dangerous to the American people.
Despite his concerns, he also acknowledged the balance that must be struck in ensuring the safety of our drugs but also the supply of drugs.
Why don't we just say, 'If you want to send medication into our country, you need to tell us precisely where it's being made, and we're going to come out and look at it.'
We must ensure that every American has access to safe medication through your quality inspection.
I find it unbelievable that for 80 years the FDA has lacked the appropriate resources and tools to ensure the safety of cosmetic and personal care products.
The number one ingredient in nonstick frying pans is also an ingredient in our cosmetics and our personal care products.





